{
    "title": "Glaxo hoping to remedy its ebbing stock as it flags up 40 experimental treatments",
    "url": "https://www.dailymail.co.uk/money/markets/article-3302764/Glaxo-hoping-remedy-ebbing-stock-flags-40-experimental-treatments.html",
    "date": "2015-11-03",
    "keywords": [
        "gsk",
        "share",
        "glaxosmithkline",
        "development",
        "cancer",
        "treatment",
        "executive",
        "sir",
        "pressure",
        "growth",
        "value",
        "price",
        "portfolio",
        "approval",
        "flagging",
        "drugsmaker",
        "commenting",
        "pfizer",
        "takeover",
        "growthin",
        "research",
        "presentation",
        "york",
        "core",
        "hiv",
        "immunoinflammation",
        "respiratory",
        "ftse",
        "company",
        "opportunity",
        "decline",
        "advair",
        "worry",
        "brummer",
        "boss",
        "life",
        "support",
        "thirdquarter",
        "article",
        "money",
        "level",
        "innovation",
        "confidence",
        "consumersseven",
        "market",
        "end",
        "decade",
        "firm",
        "saidcity",
        "spotlight",
        "remain",
        "pressuregsk",
        "cent",
        "night",
        "companys",
        "upbeat",
        "announcementsalso",
        "yesterday",
        "deal",
        "merck",
        "trial",
        "drug"
    ],
    "category": [
        "money",
        "markets"
    ]
}